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Abstract
The use of medicinal plants for the treatment of illnesses is widely known. However, there are not many scientific 
reports about the properties of these plants and their side effects. In this study, the effect of the aqueous extract 
of Origanum vulgare on the preimplantational mouse embryo development was investigated. The oregano 
aqueous extract was given ad libitum to four separated groups (n= 10) of pregnant mice: O, 9, 18 y 36 mg/mL 
respectively. When the embryos were evaluated, a slight delay in the embryo development was observed, but 
only with the highest dose. With respect to embryo quality, an increase of degenerated embryos was observed 
but this was not significant. These results showed that the aqueous extract of O. vulgare does not have a toxic 
effect on preimplantational mouse embryo, and it only produces a slight delay in embryo development. 
Key words: Preimplantational embryo, Traditional Medicine, Origanum vulgare, embryotoxicity.
Resumen
El uso de las plantas medicinales para el tratamiento de las enfermedades es ampliamente conocido. Sin em-
bargo, no hay muchos informes científicos sobre las propiedades de dichas plantas y sus efectos secundarios. 
En este estudio, se ha investigado el efecto del extracto acuoso de Origanum vulgare en el desarrollo preim-
plantacional de embriones de ratón.  El extracto acuoso fue administrado (0, 9, 18 y 36 mg/mL): vía oral; ad 
libitum, respectivamente a cuatro grupos de ratonas preñadas (n= 10). Cuando los embriones fueron evaluados 
sólamente con la dosis más alta se observó un ligero retraso en el desarrollo del embrión. Con respecto a la 
calidad del embrión, se evidencio un aumento de embriones degenerados, pero esto no fue significativo. Estos 
resultados mostraron que el extracto acuoso de O. vulgare no tiene un efecto tóxico en embriones de ratón 
preimplantacional, y sólo produce un ligero retraso en el desarrollo del embrión. 
Palabras clave: Embrión preimplantacional, Medicina tradicional, Origanum vulgare, embriotoxicidad.
Introduction
Of the 250,000 species of flowering plants in the World, more 
than 20,000 – nearly 10% of the total – are classified as herbs. 
Herbs picked by people from the wild have been an essential 
factor in health care all over the World throughout the ages and 
in all cultures. Nowadays, some 80% of the World’s people rely 
on traditional, plant-based medicines for their primary health 
care (Cosge et al. 2009). 
Actually, there exists a tendency to use natural products for 
the treatment of several illnesses. With use of medicinal plants, 
investigations have been performed all over the world in order 
to find more productive and economical medicines (Goze et 
al. 2010). Medications used to cure disorders require conti-
nuous changing to improve their effectiveness. However, few 
of the many claims of therapeutic efficacy have been validated 
adequately by clinical trials; Even though these claims have 
been substantiated scientifically, complementary medicines are 
unlikely to secure a place in conventional healthcare (Hammer 
et al. 1998).
The Labiatae family (Lamiaceae) is one of the largest and 
most distinctive families of flowering plants, with about 220 
genera and almost 4000 species worldwide (Naghibi et al. 2005); 
Labiatae are best known for the essential oils  common to many 
members of the family (Jones 1996, cited by Hammer et al. 
1999). O. vulgare "oregano" is a herb widely used in cooking 
and natural medicine (Fon Quer 1985, Naghibi et al. 2005) 
that include many effective antioxidants, such as Rosmarinic 
acid, caffeic acid and various flavonoids (Yoshino et al. 2006). 
In a study on the phenolic acids recovered in human urine after 
single ingestion of Origanum onites extract, Nurmi et al. (2006) 
identified phenolic constituent in the extract was rosmarinic 
acid, representing 75% of the identified phenolic acids. Other 
phenolic acids, including protocatechuic acid, p-coumaric acid, 
ferulic acid, chlorogenic acid and gallic acid, were present in the 
extract in notably lower amounts. The extract also contained 
minor amounts of the flavonoids luteolin and eriodictyol. In 
scientific reports about the medicinal properties of oregano: 
Origanum oil, mainly rich in carvacrol (Bakkali et al. 2008), 
is used as a painkiller in rheumatism by rubbing externally on 
painful limbs. The aromatic oregano water, rich in carvacrol, 
is consumed to check gastrointestinal disorders, reduce blood 
cholesterol and glucose level and also for tumor suppressive 
activities (Goze et al. 2010); against whooping and convulsive 
coughs, digestive disorders and menstrual problems (Gurudatt 
et al. 2010), also its calming (Lans et al. 2007), antimicrobial 
(Nazia et al. 2007) and antifungal activity is emphasized (Ha-
mmer et al. 1998, 1999; Ultee et al. 1999). In Northern Peru, 
leaves and stems, fresh or dried, of oregano are employed as 
traditional remedies for menstrual cramps, menstruation and 
lower stomach cramps related to premenstrual stages (Bussmann 
& Glenn 2010).
It is known that during the early pregnancy, the mammal 
embryo is susceptible to the toxic action of some drugs. These 
harmful effects depend on the exposure time and its concentra-
tion. At the undifferentiated stage of zygote proliferation and 
before implantation, exposure to a teratogen usually either kills 
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the fertilized ovum which results in a spontaneous abortion, or 
spares it completely (Stanley & Bower 1986). During the recent 
years there have been reports on the toxic effects of some medi-
cinal plants on the mouse embryo development (Lemonica et 
al. 1996, Gutierrez-Pajares et al. 2003). Although it is common 
to evaluate xenobiotic effects on mammalian embryos during 
organogenesis, the effects of these agents on preimplantation 
development is less commonly studied. Toxic agents or an 
unfavorable environment during preimplantation stages could 
alter normal events to arrest embryos or invoke abnormalities 
that affect subsequent stages of development. In a previous work, 
Benavides et al. (2000) found 10% of abnormal embryos when 
20% aqueous extract of oregano was orally provided to pregnant 
mice in contrast to 14,29% of abnormal embryos found in the 
control group.   
For this reason, it is necessary to evaluate and rule out the 
possible side or toxic effects that those plants could have (Be-
navides el al. 2001). The aim of this study was to examine the 
possible embryotoxicity of aqueous extract of O. vulgare on the 
mouse preimplantational embryo development.
Material and methods
Botanical samples were obtained from marketplace suppliers 
who had collected the plants from public lands. They were identi-
fied by Esther Cox, professor of Facultad de Ciencias Biológicas, 
Universidad Nacional Mayor de San Marcos. Voucher specimens 
of species studied are deposited in our laboratory.
Swiss Rockefeller strain mice from our animal house were 
maintained with a photoperiod of 14 h light/10 h dark, 22 – 24 
ºC room temperature and free access to balanced diet pellets 
(Purina, Peru). Females between six to eight weeks old were 
mated with proved fertile males between 8 – 12 weeks old. 
When a vaginal plug was observed, it was considered to be day 
one of pregnancy. 
Aqueous extract.- Leaves of O. vulgare were dried at 60 ºC 
in a stove for 24 h. The aqueous extract was prepared heating 
300 g of oregano in 1500 mL of distillated water at 60 °C for 
15 minutes, and then the extract was decanted. After filtration, 
a sample was separated for determination of the solid concen-
tration (36 mg/mL). From this extract we prepared doses of O, 
9, 18 and 36 mg/mL. 
Experimental procedure.- Pregnant females were randomly 
assigned to four experimental groups:  Group Control, Group 
A, Group B and Group C, each group (n= 10) was orally treated 
with 0, 9, 18 and 36 mg/mL ad libitum of aqueous extract of 
oregano, respectively since day one to day four. Female mice were 
euthanized by cervical dislocation 96 hours post copula (h.p.c.) 
and oviducts and uterine horns were excised, preimplantational 
embryos were collected by flushing oviducts and uterine horns 
with phosphate buffer saline (PBS, Sigma) pH 7,4 supplemented 
with 4 g/L bovine serum albumin (BSA. Sigma Chemical Co.) 
(Hogan et al. 1986). 
Evaluation of embryo morphology and transport.- The 
stage and embryo quality were evaluated under a phase contrast 
microscopy and the grade of viability was determined by doing 
a morphological evaluation following Dorn & Kramer (1987) 
protocol with some of our own modifications (Figure 1): 
Grade 1:   there are no extruded blastomeres and the embryo 
has a rounded appearance.
Grade 2: there are extruded blastomeres and the embryo may 
not have a rounded appearance. 
Grade 3: there are several extruded blastomeres and the 
embryo may be extremely malformed.
Degenerated: The embryo may be flat or bowl shape and 
most of the membranes are broken down.
Statistical analysis.- Data was evaluated by chi-square or 
Fisher test and all results with p<0,05 were considered statisti-
cally significant.
Results
This is not the first time that our laboratory demonstrated 
that oral administration of an aqueous extract of an herb causes 
damage to preimplantation mouse embryos (Gutierrez-Pajares 
2003, Gonzales et al. 2007). In this time, this effect is not related 
to a systemic toxicity since there was no sign of intoxication in 
any of the doses in the pregnant mice. 
Table 1 and 2 show the effects of treatment with aqueous 
extract of oregano on the early development stages of mouse 
embryo. Groups A and B did not show a significant difference 
when they were compared with the group control. There was 
Figure 1. Gradation of 96 hpc preimplantational embryos.
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not a similar results in group C where blastocyst stage decreased; 
41,89% in comparison with the control, where it was 56,46% 
(p< 0,05). A significant increase in the morulae stage was obser-
ved in the same group, demonstrating a slight delay in embryo 
development with the highest dose.
When the embryo quality was examined, we found a sig-
nificant increase in the occurrence of degenerated embryos in 
all treated groups in comparison with group control (group A: 
13,6%, group B: 9,72%, group C: 13,51% and group control: 
5,06%). Also, a significant increase in the number of grade 1 
embryos was observed in group B 65, 28% in comparison with 
group control 46,84%. A significant decrease in grade 2 embryos 
in groups A and B was observed. In the same way there was a 
significant decrease in grade 3 embryos in group C (Table 2). 
Discussion
Domaracký et al. (2007) did not found influence of essential 
oil of O. vulgare (carvacrol, 65%) on mouse preimplantational 
in vivo, however, the embryos was altered only minimally and 
appeared as an increase of cell death. In our results, there was a 
significant decrease in grade 3 embryos in group C (Table 2) as 
well. There are not many scientific reports about toxic activity 
of O. vulgare.  Many studies exist in which antimicrobial activity 
from O. vulgare is confirmed. However plants oils and extracts 
are to be used for food preservation or medicinal purposes, issues 
of safety and toxicity will need to be addressed (Hammer et al. 
1999). It has been reported that O. vulgare  contains substances 
that have progestin bioactivity (Zava et al. 1998, Arcila-Lozano 
2004), these substances have an action similar to progesterone, 
and they could act in favor of normal embryo development, 
which is evidenced by the increase of grade 1 embryos in all 
treated group, although this increase is only significative in group 
B. Furthermore, there are reports that O. vulgare has antioxidant 
effects (Yoshino et al. 2006, Jaloszyńsky et al. 2008) in front 
to the DPPH action, this effect is attributed to the rosmarinic 
acid (Yoshino et al. 2006) and its derivatives presents in this 
plant, conferring to O. vulgare a protecting character against 
cell damage by oxidation (Lamaison et al. 1990) or reducing 
the expression of the proinflammatory gene cyclooxygenase-2 
(COX-2), which has been regarded as a risk factor in tumor 
development (Scheckel et al. 2008). Arcila-Lozano (2004) affirm 
that the essential oil from Origanum have the property to increase 
the activity of the detoxicant enzyme, glutation S-transferase 
when it is administered orally. 
In conclusion; this study shows that aqueous extract of O. 
vulgare does not have a toxic effects on development and mor-
phology of preimplantational mouse embryo; only with the 
highest dose, a significant delay in the formation of blastocysts 
was observed.
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1-8 cells Morulae Blastocysts
Control 13,93 (11) 29,11 (23) 56,96 (45)
Group A 12,35 (10) 19,75 (16) 67,9 (55)
Group B 9,72 (7) 34,72 (25) 55,56 (40)
Group C 6,76 (5) 51,35 (38)* 41,89 (31)*
Table 1. Number and percentage of embryos by stage obtained from 
females treated with aqueous extract of oregano.
Numbers in parenthesis represent quantity of evaluated embryos. Asterisks des-
ignate significant differences between the control and treated groups (*p < 0,05). 
Grade 1 Grade 2 Grade 3 Degenerate
Control 46,84 (37) 32,91 (26) 15,19 (12) 5,06 (4)
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Table 2.  Number and percentage of embryo quality obtained from females treated with aqueous extract of oregano. Control vs. treated groups.
Numbers in parenthesis represent quantity of evaluated embryos. Asterisks designate significant differences between the 
control and treated groups (*p < 0.05).
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